Search Finnegan

Our Work

7 results

Experience

Rare PTAB rehearing request granted for Finnegan client Incyte Rare PTAB rehearing request granted for Finnegan client Incyte

IPR2017-01256, PTAB, Judges Fitzpatrick, Hulse, Yang, Smith, Franklin
19-2011, Fed. Cir., Judges Hughs, Linn, Stark

Experience

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Experience

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Experience

Prosecuting patents for startup Hutchison Medipharma

Prosecuting patents for startup Hutchison Medipharma

Hutchison Medipharma

Experience

Startup sold to major drug company based on strength of patents Startup sold to major drug company based on strength of patents

Agouron Pharmaceuticals, Inc.

Experience

Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal

Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal

Principia Biopharma

Our Insights

16 results

Conference

Life Sciences Patent Network North America Spring Life Sciences Patent Network North America Spring

April 29-30, 2026

Boston

Articles

The Interplay of Patent Term Extension (PTE) and Reissue: Merck v. Aurobindo and Its Implications, Part I

The Interplay of Patent Term Extension (PTE) and Reissue: Merck v. Aurobindo and Its Implications, Part I The Interplay of Patent Term Extension (PTE) and Reissue: Merck v. Aurobindo and Its Implications, Part I

April 7, 2026

Articles

The Interplay of Patent Term Extension (PTE) and Reissue: Merck v. Aurobindo and Its Implications, Part II

The Interplay of Patent Term Extension (PTE) and Reissue: Merck v. Aurobindo and Its Implications, Part II

The Interplay of Patent Term Extension (PTE) and Reissue: Merck v. Aurobindo and Its Implications, Part II

April 7, 2026

Articles

Skinny Labels, Larger Risks: Supreme Court Considers Induced Infringement Standards in Hikma v. Amarin

Skinny Labels, Larger Risks: Supreme Court Considers Induced Infringement Standards in Hikma v. Amarin Skinny Labels, Larger Risks: Supreme Court Considers Induced Infringement Standards in Hikma v. Amarin

March 3, 2026

Westlaw Today

European IP Blog

T 1994/22 – Polymorphs and Plausibility T 1994/22 – Polymorphs and Plausibility

21 November 2024

Hybrid Conference

2024 ACC SFBA Life Sciences Conference 2024 ACC SFBA Life Sciences Conference

March 19-21, 2024

Brisbane

Prosecution First Blog

Life Sciences Patent Drafting Tool: MPF Claims Life Sciences Patent Drafting Tool: MPF Claims

September 15, 2023

Webinar

General Information on English Contracts for Pharmaceutical Products General Information on English Contracts for Pharmaceutical Products

February 22, 2022

Webinar

News

2 results

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Westlaw Today

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Axios